The Valley Desk

ArticleThe oncologistPublished

Biweekly dosing of trifluridine-tipiracil reduces rates of myelosuppression while maintaining efficacy in patients with metastatic colorectal cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
The oncologist
Published
Subject terms
Humans; Colorectal Neoplasms; Neoplasm Metastasis; Anemia; Neutropenia; Thymine; Pyrrolidines; Trifluridine; Drug Combinations; Drug Administration Schedule; Retrospective Studies; Adult
PubMed ID
40421955
PubMed Central ID
PMC12107540
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal